Skip to content

Medical-device intelligence

QDK: Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management

FDA product code QDK: Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QDK
FDA device name
Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management
Device class
2
Regulation number
862.1355
Medical specialty
Clinical Chemistry
Review panel
CH

FDA definition

An integrated continuous glucose monitoring system for non-intensive diabetes management is intended to replace finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes who do not have significant risk of severe hypoglycemia. The device also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating long-term therapy adjustments. The device is also intended to autonomously communicate with digitally connected devices. The device can be used alone or in conjunction with these digitally connected devices or services for the purpose of managing diabetes.
Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Oct 26, 2018 to Aug 17, 2021.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

4 matching records
Device / recordCompany in FDA recordSourceSource date
Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) SystemK203089 · QDKDexcom, Inc.510(k)Aug 17, 2021FDA decision date
Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) SystemK193642 · QDKDexcom, Inc.510(k)Jan 29, 2020FDA decision date
Dexcom G6 Glucose Program Continuous Glucose Monitoring (GCM) SystemK192787 · QDKDexcom, Inc.510(k)Oct 25, 2019FDA decision date
Dexcom G6 Glucose Program Continuous Glucose Monitoring SystemK182041 · QDKDexcom, Inc.510(k)Oct 26, 2018FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗